A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in European Patients in the Course of Routine Clinical Care (I5Q-MC-B002)

First published 17/01/2019

Last updated 28/10/2024

EU PAS number:

EUPAS27594

Study

Ongoing

Documents

Study protocol

Initial protocol

I5Q-MC-B002 Galcanezumab_EU Long Term Safety_Drug Utilization_Protocol_amendment_Redacted

English (3.6 MB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs